Switch to:
More From Other Websites
US investors double down on biotech bets Jan 22 2015
Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the U.S. Jan 21 2015
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers Jan 20 2015
With $450M sale, Alnylam has more cash than any pre-commercial biotech Jan 20 2015
Transforming medicine Jan 14 2015
Did the Cystic Fibrosis Foundation Really Do Anything Wrong? A Times' Op-Ed and the Threat to... Jan 14 2015
CEO: 2015 exciting for Vertex Jan 13 2015
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition Jan 12 2015
Vertex Pharma To Start Next-Gen Cystic Fibrosis Drug Studies Earlier Than Expected Jan 12 2015
Big deals, data kick off JPMorgan health conference Jan 12 2015
Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New... Jan 11 2015
Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New... Jan 11 2015
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth... Jan 06 2015
Time For a Biotech Pullback? Jan 06 2015
UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF... Jan 06 2015
BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies Jan 05 2015
5 Biotech Stocks With Big News Due In January Dec 31 2014
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic... Dec 29 2014
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic... Dec 29 2014
Quick Update: New Hires, Recent Panel Discussion Emphasize Confluence Of Pharma And Big Data Dec 24 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK